In support of improving patient care at the time of sudden medical emergencies, this activity has been planned and implemented by the Postgraduate Institute for Medicine and American HealthCare
Academy. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide free continuing education for the healthcare and medical team.
Students earn maximum 4.0 CE credit hours for this CPR/AED course.
Students earn maximum 2.0 credit hours for the First Aid Course.
Students enroll in this course and pass the test. They pay only for the mailed-in certificate and earn maximum 6.0 CE credit hours for this combo course.
The maximum number of credit hours for this Nursing Education activity is 8.0 contact hours.
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.0 contact hours. Continuing Nursing Education.
The maximum number of credit hours for this Nursing Education activity is 8.0 contact hours.
The maximum number of credit hours given to students for this Nursing Education activity is 4.0 contact hours.
Estimated time to complete activity: 2-6 hours.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine designates this continuing education activity for 4.0 contact hour(s) (0.40 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA4008162-9999-22-103-H04-P
Type of Activity: Application
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hour(s) (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA4008162-9999-22-103-H04-P
Type of Activity: Application
Postgraduate Institute for Medicine designates this continuing education activity for 6.0 contact hour(s) (0.60 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA4008162-9999-22-103-H04-P
Type of Activity: Application
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.
This activity was planned by and for the healthcare team, and learners will receive 24 Interprofessional Continuing Education (IPCE) credit for learning and change. (This applies only for ACLS and PALS Courses)
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers,and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest or a commercial interest.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers,and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest or a commercial interest.
Media, Internet
Internet Explorer 8.0+ for Windows 2000, 2003, XP, Vista, or Windows 7, 8, or 10
Google Chrome 18.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
Safari 4.0+ for Mac OSX 10.5+
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
During the period of [date] through [expiration date], participants must read the learning objectives and faculty disclosures and study the educational activity. In order to receive CE credit, participants must also complete the post study material evaluation quiz. Upon registering and successfully completing the quiz with a score of 75% or better, you may request for a certificate.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
